Chitosan-Shelled Nanobubbles Irreversibly Encapsulate Morpholino Conjugate Antisense Oligonucleotides and Are Ineffective for Phosphorodiamidate Morpholino-Mediated Gene Silencing of DUX4.

Nucleic Acid Therapeutics
Maria Sofia FalzaranoAlessandra Ferlini

Abstract

Orphan drugs, including antisense oligonucleotides (AONs), siRNAs/miRNAs, Cas9 nuclease, and recombinant genes, have recently been made available for rare diseases. However, the main bottleneck for these new therapies is delivery. Drugs/synthetic genes need to reach the affected tissues with minimal off-target effects and immune reactions. AON molecules are currently delivered as backboned naked compounds or via viral vectors. Nanocarriers are considered promising vehicles, able to improve drug distribution by organ targeting and limiting safety issues. We tested perfluoropentane-based nanobubbles (NBs) as vehicles for loading phosphorodiamidate morpholino (PMO) AON to suppress DUX4 expression in a facioscapulohumeral muscular dystrophy cell model. In vitro cell-free analysis demonstrated a good loading capacity of PMO into NBs, while experiments in cell cultures showed lack of therapeutic effect since expression of DUX4 and its targets remained unmodified. We conclude that these types of chitosan-shelled NBs do not release PMO-AON and are therefore not ideal for PMO AON-related therapies.

References

Feb 26, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Paola RimessiAlessandra Ferlini
Jun 26, 2009·Accounts of Chemical Research·Katherine W FerraraHua Zhang
Aug 19, 2011·International Journal of Biological Sciences·Dario Lirussi, Mariana Matrajt
Feb 23, 2012·Current Pharmaceutical Design·Nicolas A GeisRaffi Bekeredjian
Jul 18, 2012·International Journal of Nanomedicine·Roberta CavalliDavid Lembo
May 18, 2013·Advanced Drug Delivery Reviews·Koen RaemdonckStefaan C De Smedt
May 21, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Sarah L DeVos, Timothy M Miller
Sep 7, 2013·International Journal of Pharmaceutics·Roberta CavalliDavid Lembo
May 28, 2014·Human Molecular Genetics·Zizhen YaoStephen J Tapscott
Dec 29, 2015·Nanomedicine : Nanotechnology, Biology, and Medicine·Kunal BhattacharyaBengt Fadeel
Feb 24, 2016·Advanced Drug Delivery Reviews·Xinwei Cheng, Robert J Lee
Feb 26, 2016·Thyroid : Official Journal of the American Thyroid Association·Francesca MaranoMaria Graziella Catalano
Apr 16, 2016·Advanced Drug Delivery Reviews·Zhigao NiuMaría J Alonso
Apr 17, 2016·Nucleic Acids Research·Rudolph L Juliano
Jul 6, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jennifer Cj ChenKathryn R Wagner
Dec 9, 2016·Nucleic Acid Therapeutics·Annemieke Aartsma-Rus, Arthur M Krieg
Mar 16, 2017·EMBO Molecular Medicine·Caroline GodfreyVirginia Arechavala-Gomeza
Apr 6, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Valentina SardoneMaria Sofia Falzarano
Dec 15, 2017·Nucleic Acids Research·Xiulong Shen, David R Corey
Jan 11, 2018·Current Pharmaceutical Design·Maria Sofia FalzaranoAlessandra Ferlini
Feb 8, 2018·Molecular and Cellular Pediatrics·Kelly M MartinovichStephen M Stick
Feb 13, 2018·Therapeutic Advances in Neurological Disorders·Valeria Parente, Stefania Corti
May 13, 2018·International Journal of Molecular Sciences·Anne-Charlotte MarsollierJulie Dumonceaux
May 18, 2018·Human Molecular Genetics·Lucía EchevarríaAurélie Goyenvalle
Oct 29, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Bolin WuWen Cheng
Dec 15, 2019·Nature Reviews. Drug Discovery·Erik TambuyzerMarco Prunotto
Jan 16, 2020·Cells·Sarah Bajan, Gyorgy Hutvagner

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
antisense oligoribonucleotides
antisense oligonucleotides
transfections
PCR
electrophoresis
transfection
PCRs
transfect

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.